Digital coaching increases RA patients' medicine adherence & health while reducing flares

November 04, 2017

SAN DIEGO - A 12-week, digital health coaching program with personalized support from a dedicated health coach improved well-being and decreased symptoms for participants with rheumatoid arthritis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

Rheumatoid arthritis (RA) is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Though joints are the principal body parts affected by RA, inflammation can develop in other organs as well. An estimated 1.3 million Americans have RA, and the disease typically affects women twice as often as men.

While there have been great advances in medications to treat RA in recent years, the disease still has a serious impact on the lives and well-being of millions of patients worldwide. Self-management by RA patients, including lifestyle changes to improve arthritis symptoms, is essential. Pack Health, a digital health coaching company in Birmingham, Alabama, conducted a study to examine the efficacy of a remote, behavior modification program for RA patients to help them reduce stressors related to their disease and make behavior changes proven to reduce RA symptoms and improve well-being.

"The hope was that when armed with the right information and tools and dedicated, one-on-one support on their schedule, participants would be able to improve key heath behaviors as well as key measures of disease management and overall health," said Uma Srivastava, Associate Director, Strategic Partnerships at Pack Health in Birmingham.

For the study, 127 patients with RA were enrolled in a 12-week digital health coaching program that included pairing each patient with a non-clinical health coach. Patients were contacted once a week by telephone, and these conversations centered on the principles of patient engagement and activation towards behavior change, said Srivastava.

To determine the impact of this telephone-based intervention, participants were surveyed about their behaviors and condition at baseline and after 12 weeks of coaching. The researchers collected information about the patients' mental and physical health using the PROMIS Global Health-10 survey. Patients were also asked to self-report the number of flares they experienced each month.

The study's results showed significant improvements among the participants. These included a decrease in body-mass index of 0.55 kg/m2, an increase in weekly physical activity of 76 percent, an increase in hours of sleep per night of 0.3 hours, and a 50 percent reduction in the number of medication doses missed each week.

There were also significant increases in the participants' scores in PROMIS Global Health-10, including a 13 percent increase in the survey's physical health domain and a 16 percent increase in its mental health domain. The participants' RA flare frequency also dropped by 50 percent after program completion. The researchers concluded that this finding suggests symptom relief is associated with improvements in healthy behaviors and stressor reduction.

"Often, patients with RA are overwhelmed, and they require both coaching and care coordination to improve their well-being. However, rheumatologists often lack the time, tools and training required to effectively coach patients in the office environment," said Srivastava. "This study shows that incorporating tools such as digital remote patient coaching into the workflow of clinicians can support better outcomes, patient experience and health care utilization. In turn, clinicians are able to overcome barriers such as time, cost and patient non-adherence to recommended care."
-end-
About the ACR/ARHP Annual Meeting

The ACR/ARHP Annual Meeting is the premier meeting in rheumatology. With more than 450 sessions and thousands of abstracts, if offers a superior combination of basic science, clinical science, tech-med courses, career enhancement education and interactive discussions on improving patient care. For more information about the meeting, visit https://www.rheumatology.org/Annual-Meeting, or join the conversation on Twitter by following the official #ACR17 hashtag.

About the American College of Rheumatology

The American College of Rheumatology is an international medical society representing over 9,400 rheumatologists and rheumatology health professionals with a mission to empower rheumatology professionals to excel in their specialty. In doing so, the ACR offers education, research, advocacy and practice management support to help its members continue their innovative work and provide quality patient care. Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases. For more information, visit http://www.rheumatology.org.

American College of Rheumatology

Related Rheumatoid Arthritis Articles from Brightsurf:

Reducing dementia in patients with rheumatoid arthritis
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Rheumatoid arthritis patients under treatment with methotrexate
Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

Rheumatoid arthritis -- can its onset be delayed or prevented?
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs.

Disease burden in osteoarthritis is similar to rheumatoid arthritis
Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Rheumatoid arthritis meets precision medicine
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new multi-site study.

Read More: Rheumatoid Arthritis News and Rheumatoid Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.